Articles published by GlobeNewswire
XCharge Reports 61% Year-over-Year Revenue Growth in Third Quarter 2026
November 10, 2026
From XCHG LIMITED
Via GlobeNewswire
Tickers
XCH
PMGC Holdings Inc. Announces Strategic Share Acquisition in Australian Space Technology Company Orbit2Orbit
November 10, 2026
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers
ELAB
Xilio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Pipeline and Business Updates
November 10, 2026
Via GlobeNewswire
Tickers
XLO
Via GlobeNewswire
Arbutus Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 10, 2026
Via GlobeNewswire
Tickers
ABUS
Exagen Inc. Reports Third Quarter 2026 Financial Results
November 10, 2026
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
From Ardelyx, Inc.
Via GlobeNewswire
Tickers
ARDX
Cellectar Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
November 10, 2026
Via GlobeNewswire
Tickers
CLRB
Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN
November 10, 2026
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Hemab Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 10, 2026
Via GlobeNewswire
Tickers
COAG
Via GlobeNewswire
Tickers
IMTX
Gain Therapeutics Reports Financial Results for Third Quarter 2026 and Provides Corporate Update
November 10, 2026
Via GlobeNewswire
Tickers
GANX
From Olema Oncology
Via GlobeNewswire
Tickers
OLMA
Sionna Therapeutics Reports Third Quarter 2026 Financial Results
November 10, 2026
Via GlobeNewswire
Tickers
SION
Palomino Laboratories to Participate in the Stifel Deep Tech Forum on December 7, 2026
November 10, 2026
Via GlobeNewswire
Tickers
PALX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
